Investigation of genetic predictors of the response to SSRI treatment in patients with panic disorder.

Trial Profile

Investigation of genetic predictors of the response to SSRI treatment in patients with panic disorder.

Completed
Phase of Trial: Phase IV

Latest Information Update: 17 Jun 2016

At a glance

  • Drugs Escitalopram (Primary)
  • Indications Major depressive disorder; Panic disorder
  • Focus Adverse reactions; Pharmacogenomic; Therapeutic Use
  • Most Recent Events

    • 05 Sep 2015 Status changed from recruiting to completed as per European Clinical Trials Database record.
    • 26 Jul 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top